On 1/6/25, Atara Biotherapeutics Inc (NASDAQ: ATRA) stock enjoyed a major increase of 10.1%, closing at $18.00. Moreover, this advance was accompanied by unusually high trading volume at 162% of normal. Relative to the market the stock has been weak over the last nine months but has risen 38.7% during the last week.
Current PriceTarget Research Rating
Atara Biotherapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment